All In Biotech

Drug Trial Radar · NCT00002523

Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed

FOUR ARMS PHASE III CLINICAL TRIAL FOR T3-T4 RESECTABLE RECTAL CANCER COMPARING PRE-OPERATIVE PELVIC IRRADIATION TO PRE-OPERATIVE IRRADIATION COMBINED WITH FLUOROURACIL AND LEUCOVORIN WITH OR WITHOUT POST-OPERATIVE ADJUVANT CHEMOTHERAPY

Last checked: Nov 20, 2026Latest source record: Sep 2, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,011 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,011

Actual

Start

Apr 1993

Primary completion

Mar 2003

Study completion Jan 2016

Sponsor

Sponsor type
Research network
First posted
Jan 27, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Primary purpose
Treatment
Who can join
All sexes, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug, giving the drugs in different ways, and combining radiation therapy and surgery with chemotherapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare radiation therapy alone before surgery with radiation therapy plus fluorouracil and leucovorin before surgery, with and without fluorouracil and leucovorin after surgery in patients with rectal cancer that can be surgically removed.

Conditions

  • Colorectal Cancer

Interventions

  • fluorouracilDrug

  • leucovorin calciumDrug

  • conventional surgeryProcedure

  • radiation therapyRadiation

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

35 sites in 10 countries. Site status is shown where the registry gives one.

  • Institut Jules Bordet

    Brussels, Belgium

  • Hopital Universitaire Erasme

    Brussels, Belgium

  • Hopital Civil de Charleroi

    Charleroi, Belgium

  • Centre Hospitalier Universitaire de Tivoli

    La Louvière, Belgium

  • Clinique Sainte Elisabeth

    Namur, Belgium

  • Centre Paul Papin

    Angers, France

  • Institut Sainte Catherine

    Avignon, France

  • Centre Hospitalier General

    Belfort, France

  • CHR de Besancon - Hopital Jean Minjoz

    Besançon, France

  • C.H.U. de Brest

    Brest, France

  • Centre Hospitalier Universitaire Henri Mondor

    Créteil, France

  • Centre de Lutte Contre le Cancer, Georges-Francois Leclerc

    Dijon, France

  • CHR de Grenoble - La Tronche

    Grenoble, France

  • Centre Oscar Lambret

    Lille, France

  • Centre Hospital Regional Universitaire de Limoges

    Limoges, France

  • Service Cancerologie Polyclinique Clairval

    Marseille, France

  • CRLCC Nantes - Atlantique

    Nantes-Saint Herblain, France

  • Clinique De Valdegour

    Nîmes, France

  • Hopital Jean Bernard

    Poitiers, France

  • Clinique Sainte Clotilde

    Sainte Clotilde, France

  • Centre Paul Strauss

    Strasbourg, France

  • Centre Hospitalier Universitaire Bretonneau de Tours

    Tours, France

  • Centre Saint-Yves

    Vannes, France

  • Krankenhaus des Kreises Hameln-Pyrmont

    Hamelin, Germany

  • Rambam Medical Center

    Haifa, Israel

  • University Medical Center Nijmegen

    Nijmegen, Netherlands

  • Dr. Bernard Verbeeten Instituut

    Tilburg, Netherlands

  • Medical University of Gdansk

    Gdansk, Poland

  • Institute of Oncology and Radiology of Serbia

    Belgrade, Serbia

  • Hospital General Universitari Vall d'Hebron

    Barcelona, Spain

  • Institut Catala d'Oncologia - Hospital Duran i Reynals

    Barcelona, Spain

  • Hospital General Gregorio Maranon

    Madrid, Spain

  • Kantonsspital Basel

    Basel, Switzerland

  • UniversitaetsSpital

    Zurich, Switzerland

  • Dokuz Eylul University School of Medicine

    Izmir, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.